156 related articles for article (PubMed ID: 17051958)
1. Haematological toxicity in patients treated with cisplatin and gemcitabine for bladder cancer: the Weston Park Hospital, Sheffield, experience.
Clenton SJ; Kirkbride P; Ferguson CJ
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):639. PubMed ID: 17051958
[No Abstract] [Full Text] [Related]
2. [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma].
Gunlusoy B; Arslan M; Vardar E; Degirmenci T; Kara C; Ceylan Y; Kozacıoğlu Z
Actas Urol Esp; 2012 Oct; 36(9):515-20. PubMed ID: 22819345
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.
Gschwend JE
Eur Urol; 2007 Aug; 52(2):486-7. PubMed ID: 17383081
[No Abstract] [Full Text] [Related]
4. Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.
Linardou H; Aravantinos G; Efstathiou E; Kalofonos C; Anagnostopoulos A; Deliveliotis C; Bafaloukos D; Athanasios Dimopoulos M; Bamias A;
Urology; 2004 Sep; 64(3):479-84. PubMed ID: 15351574
[TBL] [Abstract][Full Text] [Related]
5. Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.
Sherif A
Int Braz J Urol; 2007; 33(6):840-1. PubMed ID: 18199355
[No Abstract] [Full Text] [Related]
6. Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
Park JH; Lee SW; Kim HS; Kang SG; Ko YH; Kim ST; Kang SH; Park YJ; Choi IK; Oh SC; Sung DJ; Seo JH; Cheon J; Kim YH; Kim JS; Park KH
Cancer Chemother Pharmacol; 2013 Apr; 71(4):1033-9. PubMed ID: 23370665
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
Gunaratne DA; Krieger LE; Maclean F; Vaux KJ; Chalasani V
Clin Genitourin Cancer; 2016 Feb; 14(1):e103-5. PubMed ID: 26431887
[No Abstract] [Full Text] [Related]
8. Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ; Winquist EW; Murray N; Tannock IF; Huan S; Bennett K; Walsh W; Seymour L
J Clin Oncol; 1999 Sep; 17(9):2876-81. PubMed ID: 10561365
[TBL] [Abstract][Full Text] [Related]
9. A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
Siefker-Radtke AO; Dinney CP; Shen Y; Williams DL; Kamat AM; Grossman HB; Millikan RE
Cancer; 2013 Feb; 119(3):540-7. PubMed ID: 22914978
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.
Türkölmez K; Bedük Y; Baltaci S; Göğüş C; Göğüş O
Eur Urol; 2003 Dec; 44(6):682-6. PubMed ID: 14644120
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.
Hussain SA; Stocken DD; Riley P; Palmer DH; Peake DR; Geh JI; Spooner D; James ND
Br J Cancer; 2004 Aug; 91(5):844-9. PubMed ID: 15292922
[TBL] [Abstract][Full Text] [Related]
12. Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.
Carles J; Suárez C; Mesía C; Nogué M; Font A; Doménech M; Suárez M; Tusquets I; Gallén M; Albanell J; Fabregat X
Clin Transl Oncol; 2006 Oct; 8(10):755-7. PubMed ID: 17074675
[TBL] [Abstract][Full Text] [Related]
13. Impact of Gemcitabine and Cisplatin with radiotherapy in locally advanced or metastatic transitional cell carcinoma of urinary bladder.
Mallick JA; Ali SA; Siddiqui N; Fareed A
J Pak Med Assoc; 2003 Nov; 53(11):547-52. PubMed ID: 14738263
[TBL] [Abstract][Full Text] [Related]
14. Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.
Lorusso V; Crucitta E; Silvestris N; Rosati G; Manzione L; De Lena M; Palmeri S; Gebbia V; Mancarella S; Sobrero A; Pezzella G; Comella P; Mangiameli A; Muci D;
Oncol Rep; 2005 Feb; 13(2):283-7. PubMed ID: 15643512
[TBL] [Abstract][Full Text] [Related]
15. Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.
Pectasides D; Glotsos J; Bountouroglou N; Kouloubinis A; Mitakidis N; Karvounis N; Ziras N; Athanassiou A
Ann Oncol; 2002 Feb; 13(2):243-50. PubMed ID: 11886001
[TBL] [Abstract][Full Text] [Related]
16. [Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancer].
Bodrogi I
Magy Onkol; 2003; 47(2):198-203. PubMed ID: 12975670
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Song Y; Yang L; Zhou A; Chi Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):212-6. PubMed ID: 24785283
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder.
Eroglu Z; Fruehauf JP
Cancer Chemother Pharmacol; 2013 Jul; 72(1):263-7. PubMed ID: 23636451
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.
Adamo V; Magno C; Spitaleri G; Garipoli C; Maisano C; Alafaci E; Adamo B; Rossello R; Scandurra G; Scimone A
Oncology; 2005; 69(5):391-8. PubMed ID: 16319510
[TBL] [Abstract][Full Text] [Related]
20. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]